LONDONIn the latest of a string of drugdevelopment setbacks GlaxoSmithKline PLC on Tuesday stopped a latestage trial of its cancer vaccine after disappointing results  The UK drug company had said last month that its immunotherapy treatment didnt boost survival rates among patients with nonsmallcell lung cancer a prevalent form of the disease  
  